Evidence map›Paper›PMID 40169739›Full record

ArticleScientific reports2025

Exploring the synergistic effect of MXene@ZIF-8 hybrid composites for water treatment.

Parisa Taherpoor, Farzaneh Farzad

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Parisa TaherpoorDepartment of Chemistry, University of Birjand, Birjand, Iran.
Farzaneh FarzadDepartment of Chemistry, University of Birjand, Birjand, Iran. ffarzad5487@birjand.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to their exceptional physical and chemical properties, MXenes have been the focus of growing research attention for their potential to effectively eliminate a wide range of pollutants from the aquatic environment. However, disadvantages such as limited adsorption capacity due to low specific surface area and undeveloped porosity have led to challenges in using these materials. In this work, we use a well-known MXene, Ti3C2Tx, by decorating zeolitic imidazole frameworks (ZIF-8) between MXene layers (MX@ZIF) to remove methyl orange (MO) and ciprofloxacin (CIP), as well as, the effect of -O and -OH terminal groups on adsorption efficiency of MX@ZIF substrate is investigated. Our findings from molecular dynamics simulations showed that the MXO@ZIF and MXOH@ZIF systems have stronger electrostatic interactions than the MX@ZIF system due to the formation of hydrogen bonds between the -O, -OH terminal groups from the substrates and heteroatoms of pollutant molecules. Moreover, the van der Waals energy values in the MXOH@ZIF-CIP and MXOH@ZIF-MO systems are - 253.454 and - 201.660 kJ/mol, respectively, demonstrating the effective adsorption and removal of contaminants by designed substrates. The MD results show that the van der Waals interaction has a greater contribution than the electrostatic interaction in studied systems. Also, the number of contacts of pollutant molecules with the substrate increases with time, and the highest number of contacts belongs to the MXOH@ZIF-CIP and MXOH@ZIF-MO complexes, demonstrating that this substrate has a greater tendency to adsorb pollutants. Furthermore, the results of AIM calculations confirm the presence of non-covalent interactions between pollutant molecules and studied substrates. This study shows that MXOH/ZIF can be considered a promising high-performance adsorbent for removing organic dyes and antibiotics.

Identifiers

PMID40169739
PMCPMC11961707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.